Previous Article | Next Article ![]()
Infect Immun, January 1998, p. 224-231, Vol. 66, No. 1
Immunobiology Research Institute Siena,
Department of Molecular Biology, Chiron Vaccines, 53100 Siena,
Italy,1 and
Departamento de
Genética e Evolução, Instituto de Biologia,
Universidade Estadual de Campinas, CEP 13081-970 Campinas,
Brazil2
Received 15 August 1997/Returned for modification 3 October
1997/Accepted 13 October 1997
The effects of heterologous gene dosage as well as Salmonella
typhimurium strain variability on immune response toward both the
heterologous antigen, the nontoxic mutant of the Escherichia coli heat-labile enterotoxin LTK63, and the carrier
Salmonella strain have been analyzed. Effects of a single
integration into the host DNA and different-copy-number episomal
vectors were compared in S. typhimurium Enterotoxigenic Escherichia
coli strains produce a plasmid-encoded heat-labile enterotoxin
(LT) (15, 34) related to cholera toxin (CT) (9,
35). LT is composed of two subunits, A and B, which are exported
to the periplasmic space, where they assemble into an AB5
multimeric complex (16). Several mutants of LT-A have been
constructed, and in particular, a nontoxic mutant which contains a
substitution of serine 63 with lysine (LTK63) has been shown to
maintain the structural and immunogenic properties of wild-type LT
(21, 27, 28). LTK63 has also been found to display the
strong mucosal adjuvant activity pertaining to wild-type LT. Efficient
induction of mucosal immune response, specifically in the mouse vagina,
has been achieved via the intranasal route of immunization
(10). For the development of oral vaccines, however, it
would be desirable to exploit the properties of LTK63 for enhancing
antigen-specific immune response in the intestinal mucosa by means of
oral delivery of the potent mucosal adjuvant.
Oral delivery of antigens by live vaccines is known to lead to a more
effective production of antigen-specific antibodies in mucosal
secretions than oral administration of the soluble antigen (36,
39). Several antigen delivery systems which use as carriers
mutant intracellular pathogens that have lost the ability to persist
and produce the disease while retaining limited growth in vivo have
been developed. In particular, attenuated Salmonella mutants
are suitable immunological carriers for virulence determinants from
other enteric bacteria in that they can induce humoral immune response
selectively at the site of colonization, the gut mucosa. Vaccine
strains of Salmonella have been successfully attenuated by
introducing different types of mutations (5, 8, 23, 26).
Notably, Salmonella strains with a galactose epimerase
(galE) mutation (18) or deletions in genes for
the biosynthesis of aromatic compounds (aro mutants)
(11, 12, 17, 19) or in the adenylate cyclase
(cya) and cyclic AMP receptor protein (crp) genes
(6) are the most extensively characterized.
Delivery of the B subunit of the E. coli enterotoxin (LT-B)
by a galE mutant of Salmonella typhimurium has
been shown to elicit low levels of anti-LT-B serum and mucosal
antibodies. Since the vector used for expression of LT-B was rapidly
lost in vivo, i.e., in the absence of the antibiotic required for
selection of the plasmid, the level of immune response could be
correlated only with the amount of antigen expressed during the initial
phase of invasion (3).
Recently, direct comparison between the aroA
aroD/pnirB and the Strains, plasmids, and media.
The bacterial strains and
plasmids used are listed in Table 1. The
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Levels of Expression and Immunogenicity of
Attenuated Salmonella enterica Serovar Typhimurium Strains
Expressing Escherichia coli Mutant Heat-Labile
Enterotoxin

![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
cya
crp
asd strains of two different serotypes, UK-1 and SR-11.
Expression of the enterotoxin in the different Salmonella
isolates in vitro was found to vary considerably and, for the episomal
vectors, to correlate with the plasmid copy number. LTK63-specific
serum immunoglobulin G (IgG) and mucosal immunoglobulin A (IgA)
antibodies were highest in mice immunized with the
high-level-expression strain. High anti-LTK63 IgG and IgA titers were
found to correspond to higher anti-Salmonella immunity,
suggesting that LTK63 exerts an adjuvant effect on response to the
carrier. Statistically significant differences in anti-LTK63 immune
response were observed between groups of mice immunized with the
attenuated
cya
crp UK-1 and SR-11 derivatives
producing the antigen at the same rate. These data indicate that the
same attenuation in S. typhimurium strains of
different genetic backgrounds can influence significantly the immune
response toward the heterologous antigen. Moreover, delivery of the
LTK63 enterotoxin to the immune system by attenuated S. typhimurium strains is effective only when synthesis of the
antigen is very high during the initial phase of invasion, while
persistence of the S. typhimurium strain in deep
tissues has only marginal influence.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
cya
crp
asd/asd+ delivery systems for the ability to induce
humoral and cellular immunity after a single immunization showed that
the former vaccine strain had greater potential as a carrier for
antigen delivery (20). However, the balanced lethal
asd system for in vivo selection of plasmids expressing
heterologous antigens in the attenuated
cya
crp
asd
strains is still very attractive in that asd+
plasmids do not require antibiotic resistance markers for selection while stably maintained in vivo (24). In addition, the
cya
crp
asd/asd+ delivery system has
been reported to induce protective immunity against several pathogens
(25, 29, 40). Most of these studies have restricted analysis
of the immune response to antigens expressed from the same
asd+ plasmid carried by
cya
crp
asd mutants usually of the same S. typhimurium
serotype. In this work, we have analyzed the influence of heterologous
gene dosage, and thus level of expression, as well as S. typhimurium strain variability on immune response toward both the
heterologous antigen, a nontoxic mutant of E. coli LT, and
the carrier Salmonella strain. Effects of a single
integration into the host DNA and episomal vectors at different copy
numbers were compared in S. typhimurium strains of two
different
cya
crp
asd serotypes, UK-1 and SR-11.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
cya
crp
asd S. typhimurium strains were kindly
provided by Roy Curtiss III, Washington University, St. Louis, Mo.
TABLE 1.
Bacterial strains and plasmids used
asd Salmonella strains, the amino acids methionine (20 µg/ml), threonine (8 µg/ml),
isoleucine (20 µg/ml), and/or diaminopimelic acid (50 µg/ml) were
added to the culture media.
For immunization experiments, bacteria from static overnight cultures
were diluted 1:20 in prewarmed LB and grown at 37°C under aeration to
give 109 CFU/ml. CFU were determined by plating serial
dilutions of cultures of LB agar plates or Difco MacConkey base
supplemented with 1% maltose and nalidixic acid for strains
4072
and
4217.
DNA manipulations.
Extraction and purification of plasmid
DNA were carried out as described by Sambrook et al. (31).
Genomic DNA extraction was performed as described by Rossolini et al.
(30). Southern blot experiments were performed by
bidirectional transfer of DNA from agarose gels to nylon membranes.
Specific DNA probes were obtained amplifying DNA sequences by PCR and
labeled with [
-32P]dATP, using the random-primers
method.
6212
and then purified and transformed into the attenuated S. typhimurium strains. Transformants were selected in LB medium. The
fermentation pattern, auxotrophic requirements, and lipopolysaccharide
content were routinely analyzed in all strains. The completely smooth
lipopolysaccharide was examined by polyacrylamide gel electrophoresis
(PAGE) and silver staining after periodic acid treatment
(38).
The number of copies per cell of each construct was determined by
Southern blot analysis of total DNA extracted from the different strains, digested with BamHI and SalI, and
hybridized to an elt-specific probe and to a probe specific
for the spvC gene of S. typhimurium. The
relative intensity of the elt-specific band was calculated by using a densitometer (Ultroscan; LKB).
The nucleotide sequence of mini-Tn5 asd eltK63 insertions
was determined from DNA fragments obtained by inverse PCR. Briefly, SalI-XhoI-digested genomic DNA fragments were
incubated with T4 DNA ligase overnight at 15°C. Inverse PCR was
performed by using an Expand 20 kbplus PCR kit (Boehringer)
in a total volume of 50 µl with 6 ng of DNA (2 µl of the ligation
mixture) as a template and 300 nM each of the following primers:
5'-ACAGACGTGAGCCTGAAAGGTTTGG-3' and 5'-CTTCCACTACAGGGAGCTGTTATAGC-3' (complementary to the
promoter and to the 3' end of the coding region of eltK63,
respectively).
SDS-PAGE and immunoblot analysis. Bacterial cultures were grown to the logarithmic or stationary phase in LB broth. Cells were collected and lysed by boiling (5 to 10 min) in LSB buffer (2% sodium dodecyl sulfate [SDS], 10% glycerol, 100 mM dithiothreitol, 62.5 mM Tris-HCl [pH 6.8]). Total proteins in cell extracts were quantified with a micro-bicinchoninic acid protein assay reagent kit (Pierce, Rockford, Ill.). Proteins were separated by SDS-PAGE (15% polyacrylamide gel) and transferred to nitrocellulose membranes. Mouse polyclonal anti-LT antiserum was used as the primary antibody. Bands were visualized by enhanced chemiluminescence (Amersham Life Science) or with 4-chloro-1-naphthol (Sigma) as the substrate. Evaluation of the amount of LT produced by the different strains was obtained by densitometric analysis of bands, using purified enterotoxin or CT as a reference.
Immunization and sampling. Groups of five or seven 6- to 8-week-old female BALB/c mice (Charles River, Calco, Como, Italy) were immunized intragastrically with two or four doses containing ca. 8 × 108 CFU of each Salmonella strain. Mice were deprived of water and food for 12 h and fed with 30 µl of 0.2 M sodium bicarbonate to neutralize stomach acidity 30 min prior to immunization. Groups of mice were immunized on days 0 and 10 to 14 or on days 0, 10, 17, and 24.
Serum samples and intestinal mucus were collected on days 14, 17, 24, 36, 50, and 66. Blood samples were collected from the retro-orbital sinus of each anesthetized mouse. To collect gut secretions, mice were sacrificed, the small intestine was excised, and the mucus was scraped from the luminal surface. Mucus samples were collected in centrifuge tubes containing 5 µl each of 0.1 M phenylmethylsulfonyl fluoride in ethanol, 1% bovine serum albumin, and 1% sodium azide. After centrifugation at 12,000 × g for 10 min at 4°C, supernatant fluids were collected, 5 µl of a solution containing 0.1 M phenylmethylsulfonyl fluoride and 1% sodium azide was added, and samples were stored at
20°C.
Spleens and Peyer's patches were removed from sacrificed animals and
processed as described by Curtiss and Kelly (6). After disruption in a Dounce tissue homogenizer, suspensions were diluted in
phosphate-buffered saline (PBS) and plated on MacConkey agar containing
1% lactose. The expected phenotype of S. typhimurium strains recovered from immunized animals was verified on MacConkey agar supplemented with 1% maltose.
ELISA for LT and Salmonella.
Individual mouse serum
and mucus samples were tested for immunoglobulin A (IgA) and IgG
antibodies against LT or whole Salmonella cells by
enzyme-linked immunosorbent assay (ELISA). A PBS solution of purified
LT (a gift from M. Pizza) was absorbed to 96-well ELISA plates
(Greiner-GmbH, Kremsmunster, Austria) at 0.2 µg per well overnight at
4°C. For anti-Salmonella antibody titration, bacteria were
grown overnight, harvested by centrifugation, and resuspended in PBS at
3 × 1011 CFU/ml. Bacteria were heat killed for 10 min
at 80°C and stored at
20°C. Each sample well was coated with 0.1 ml of this suspension diluted 100-fold in 0.1 M carbonate buffer (pH
9.6). Plates were blocked with PBS containing 0.05% Tween 20 and 1%
bovine serum albumin for 2 h at 37°C. After washing with PBS, an
anti-isotype secondary antibody (Sigma) was added and plates were
incubated for 2 h at 37°C. Serum samples were incubated with
alkaline phosphatase-conjugated goat anti-mouse IgG (
-chain
specific) antibodies, mucus samples were incubated with
biotin-conjugated goat anti-mouse IgA (
-chain specific) antibodies.
Plates were washed with PBS, developed with a solution of
p-nitrophenyl phosphate (1 mg/ml) in 1 M diethanolamine buffer (pH 9.8), and read in an ELISA reader (Titertek Multiscan) at
405 nm. Titers were expressed as the last dilution that gave an optical
density at 405 nm of 0.1. Under these experimental conditions,
preimmune samples always gave an optical density at 405 nm of <0.1
from the first dilution.
Nucleotide sequence accession number. The nucleotide sequence of the mini-Tn5 insertion in the virulence plasmid described in this work has been assigned GenBank accession no. AF025956.
| |
RESULTS |
|---|
|
|
|---|
Influence of copy number on expression level of LT-K63 in vitro. Expression of LTK63 by S. typhimurium attenuated strains carrying the eltK63 gene cloned into the pYA plasmids listed in Table 1 was examined. Western blot analysis of total-cell extracts and periplasmic fractions from logarithmic- and stationary-growth-phase cultures of the different S. typhimurium strains showed, as expected, a good correlation between the amount of LTK63 produced by each strain and the copy number of the recombinant plasmid carried by the strain. Expression of the enterotoxin gene, which is under the control of its own promoter in these constructs, was constitutive in all strains analyzed and in all conditions tested.
Representative results are shown in Fig. 1a. A fivefold difference was observed between the amount of toxin synthesized by strain
3987:pYA3074-LTK63
(Fig. 1a, lane 3) and that produced by
3987:pYA3137-LTK63 (Fig.
1a, lane 5). The medium-high-copy-number plasmid pYA3149, in turn,
could direct synthesis of LTK63 at a level slightly lower than that
found for the high-copy-number plasmid pYA3137 in the same strain (Fig.
1a; compare lanes 4 and 5). However, some differences were found
between the strains in that
4072:pYA3137-LTK63 produced the same
amount of enterotoxin as
4072:pYA3149-LTK63 but showed an unusual
growth curve with a 3-h lag phase followed by an exponential growth
phase with the same doubling time as the other strains. Furthermore, it
is noteworthy that strain
4072:pYA3137-LTK63 lysed during static
growth.
|
4072 by plasmid
pYA3137-LTK63 was due to the presence of the high-copy-number plasmid
or to toxicity of LTK63, a preliminary analysis of the attenuated
strains carrying plasmid pYA3137 with and without the eltK63
insert was carried out by plating cells from static growth onto
selective medium. Lysis was observed only for strain
4072 containing
the eltK63 insert in plasmid pYA3137. The plasmid without the insert did not cause lysis in any of the strains analyzed (data not
shown). Likely, expression of eltK63 from the
high-copy-number plasmid is toxic for strain
4072 during static
growth.
Two S. typhimurium strains,
3987-18A and
4217-10E, carrying a single-copy integration of the
eltK63 gene into the genome and producing equally high
amounts of LTK63, were also analyzed for expression of the enterotoxin.
The two strains were obtained by inserting a single copy of a
mini-Tn5 asd eltK63 minitransposon into the genomes of
S. typhimurium
3987 and
4217. It should be noted
that strain
4217 is an SR-11 derivative (33), while strain
3987 is a derivative of the S. typhimurium
UK-1 strain
3985 (14). Insertion of the mini-Tn5
asd eltK63 was found to have occurred in the same locus of the
virulence plasmid in both strains
3987-18A and
4217-10E. The
nucleotide sequence of this locus at the junction of the O end of the
minitransposon was determined from DNA fragments obtained by inverse
PCR. The locus does not show any homology to known S. typhimurium sequences (Fig. 1c).
In Fig. 1a, lane 2, the level of LTK63 production of strain
3987-18A
is compared with those of the episomal systems used for expression in
the same strain. The amount of LTK63 found in the single-copy integrant
was threefold greater than that observed for the low-copy-number
plasmid pYA3074. Figure 1b shows a direct comparison of the level of
LTK63 expression in late-logarithmic-growth-phase cultures of the
eltK63 single-copy integrants.
It was also found that in all strains analyzed, the LT was secreted to
the periplasmic space (data not shown), where presumably it is
assembled into its heterohexameric form, as it has been shown that
assembly of LT takes place in the periplasm in E. coli (16).
Serum antibody response induced by S. typhimurium
3987 expressing different levels of LTK63.
Groups of five
BALB/c mice were immunized orally with strain
3987 containing the
low-copy-number plasmids pYA3074-LT and pYA3074-LTK63 or
the high-copy-number plasmid pYA3137-LTK63. The same strain carrying
the pYA3074 vector without the LTK63 insert and the parental attenuated
asd+ strain
3985 were used as control
strains. A single oral booster dose of 8 × 108
S. typhimurium cells was administered 10 days after the
first inoculation. The Salmonella-specific IgG titers in
serum samples from immunized animals 24, 36, and 66 days after the
first dosing were found to differ significantly particularly at day 24, in that strain
3987:pYA3137-LTK63 induced an average 10-fold-higher response. A diminished, but still significant, difference was observed
at day 66 (Fig. 2). A possible
explanation for the less pronounced difference at day 66 in mice
receiving the high-copy-number plasmid strain could be that the higher
anti-Salmonella titers elicited by this strain after the
first immunization result in a reduced number of organisms able to
colonize after the second inoculum.
|
3987:pYA3074-LT and
3987:pYA3074-LTK63. When
the anti-Salmonella IgG titers induced by the two control strains are compared, it should be noted that the asd
mutation present in strain
3987 further attenuates S. typhimurium. Thus, the higher anti-Salmonella IgG
titers elicited by the asd+ strain
3985 are
presumably due to a higher persistence of this strain in deep organs
(Table 2).
|
3987 strains containing the LT or
LTK63 construct. IgG titers were found to be negligible with both
low-copy-number constructs, while samples from mice immunized with the
high-copy-number plasmid-bearing strain
3987:pYA3137-LTK63 showed
high anti-LT IgG titers at days 24 (1:10,310), 36 (1:31,310), and 66 (1:20,970).
Influence of Salmonella genetic background on the
induction of serum antibody response.
A similar immunization
scheme was extended to include oral inoculation of groups of seven
BALB/c mice with 8 × 108 cells of the three
S. typhimurium strains carrying a single-copy insertion
of the mini-Tn5 asd eltK63 minitransposon into the genomes of S. typhimurium
3987 and
4217 (Table 1).
3987-18A showed LT-specific IgG titers 10- to 100-fold higher
than those in samples from the other group of mice. It is interesting
that this occurs in spite of the fact that persistence of this
S. typhimurium strain in deep organs 50 days after
immunization was found to be over 10-fold lower than that of strain
4217-10E (Table 2) and that the levels of LTK63 produced in vitro
were equally high for the two strains (Fig. 1b). Possibly, this
may be attributed to a difference in the level of expression of LTK63
in vivo during the initial steps of invasion.
|
Differential induction of serum antibody response by high LTK63
expression.
Since the amount of enterotoxin produced by
S. typhimurium seemed the most crucial parameter in
determining a good immune response, an immunization experiment was
carried out with four doses of the S. typhimurium
strains containing the pYA3149-LTK63 and pYA3137-LTK63 constructs. The
strains carrying the medium-high-copy-number plasmid were included in
this experiment since strain
4072:pYA3137-LTK63 lysed after growth
in static culture. In addition, in order to compare this immunization
scheme with the previous ones, groups of seven mice were inoculated
with only two doses of the same plasmid-bearing S. typhimurium strains used for immunizing mice with four doses. The
immune response in these animals was evaluated only at day 66 from the
first inoculum. The results presented in Fig.
4A show that both the anti-LTK63 and the
anti-Salmonella IgG titers were highest for the group
of mice immunized with strain
3987:pYA3137-LTK63.
|
Analysis of mucosal antibody response.
Intestinal mucus
samples from mice immunized with the S. typhimurium
strains reported in Table 2 were analyzed for LTK63-specific and
Salmonella-specific IgA responses. The mean IgA titers of each group of seven mice are shown in Fig. 3B and 4B. The anti-LTK63 secretory response was clearly higher in mice inoculated with the
medium-high- and high-episomal-expression constructs (Fig. 4B) than in
mice immunized with the eltK63 integrants (Fig. 3B), with
the exception of the group immunized with strain
3987-18A. The high
anti-LTK63 IgA titers in the latter group of mice correlate well with
the anti-LTK63 serum IgG titers found in the same group (Fig. 3A),
although the variation of titers in individual mice was greater for the
IgA samples than for the IgG samples.
3987:pYA3137-LTK63
always showed higher systemic and local immune responses than the other
two groups of mice. Moreover, after the fourth immunization, higher IgG
titers were paralleled by higher IgA titers in all groups (Fig. 4, day
66).
The stability in vivo of the eltK63 constructs was assessed
by Southern blot analysis of genomic or plasmid DNA extracted from
bacteria isolated from Peyer's patches and spleens of immunized animals. All strains were found to have maintained the
eltK63 construct. Western blot analysis of cell extracts
from the same S. typhimurium isolates also confirmed
that the level of LTK63 synthesis was unchanged after the passage in
vivo (data not shown).
| |
DISCUSSION |
|---|
|
|
|---|
As most studies on attenuated Salmonella carriers have
analyzed differences in the induction of immunity between levels of antigen expression (3, 4), selection for vector maintenance in vivo, or attenuation of the delivery system (20, 37), we have compared the immune responses induced by the same antigen when
delivered by different strain-plasmid combinations. In particular, we
have analyzed a single integration into the host DNA and multicopy episomal vectors in three
cya
crp
asd strains of
different genetic backgrounds expressing a nontoxic mutant of the
E. coli LT.
A first comparison of variation in antigen delivery by the same
S. typhimurium strain in relation to different
expression levels of the antigen was made by analyzing the systemic
response in mice immunized with strain
3987 containing the low- and
high-expression constructs. The lack of an LTK63-specific immune
response in mice immunized with the low-expression construct, in
contrast to high levels of IgG antibodies elicited by the
high-expression vector, correlates with a fivefold difference in amount
of LTK63 synthesized in vitro by the two constructs. This finding
suggests that for this S. typhimurium strain, the
threshold for induction of anti-LTK63 systemic response is high (see
below). Alternatively, expression in vivo of LTK63 from the two
plasmids may not correlate with what is seen in vitro, although
expression in both constructs is driven by the same promoter.
An interesting finding of this experiment is that strain
3987:pYA3137-LTK63 induced anti-Salmonella IgG titers
significantly higher, during the first 3 to 5 weeks postimmunization,
than those induced by control strains or by low LTK63 producers. LTK63
has been previously shown to exert an adjuvant effect on immune
response to different antigens administered to mice by different routes (10).
By comparing S. typhimurium strains with different
genetic backgrounds and expressing the same amount of LTK63 from a
single integration site, the influence of strain variability could be inferred from the anti-LTK63 antibody response, while both systemic and
local immune responses to Salmonella were not significantly different for the different strains. Only strain
3987-18A could elicit high LTK63-specific IgG and IgA titers. Considering that strain
4217-10E contains the eltK63 gene integrated in the same locus of the virulence plasmid as strain
3987-18A and can persist longer in deep tissues, this result implies that very early events at
the priming of the immune response are particularly critical in the
induction of an anti-LT immune response (4). Furthermore, the
3987-18A genetic background may be intrinsically more effective in priming anti-LTK63 immune responses. The observation that high expression of the antigen is crucial during the early phase of the
induction of the immune response is consistent with the finding by
others that oral administration of Salmonella strains
expressing LT-B induces a dramatic increase in the level of mRNA of
some cytokines (e.g., interleukin-12) at mucosal sites within hours following immunization (1).
One of the advantages of the
cya
crp/asd system is the
effectiveness of the asd selection for plasmid maintenance
in vivo (7, 13, 24). As previously shown by other reports,
the stability in vivo of the asd vectors used in this study
for expression of LTK63 was found to be very high even for the
high-copy-number plasmid pYA3137. It should be noted, however, that
expression of LTK63 from the latter plasmid conferred an unusual
phenotype to strain
4072 in vitro: lysis after static growth. For
this reason, the analysis of immune response had to be extended to strains containing the medium-high-copy-number plasmid pYA3149. Comparison between both systemic and local antibody responses induced
by UK-1 and SR-11 strains expressing LTK63 from the high- or the
medium-high-copy-number plasmids clearly showed that, in addition to
any influence of the S. typhimurium strain delivering the antigen, the level of expression of the heterologous antigen is
critical for a high immune response. A 2-fold difference in amount of
LTK63 produced by strain
3987:pYA3137-LTK63 was sufficient to
enhance both IgG and IgA titers 10-fold. An adjuvant effect of LTK63
could be inferred also from these data, since higher Salmonella-specific titers correlated with higher expression
of LTK63.
In conclusion, our data indicate that the same attenuation in different genetic background S. typhimurium strains, expressing the recombinant antigen at the same level, can produce significantly different immune responses. Moreover, delivery of the LTK63 antigen to the immune system by attenuated S. typhimurium strains is effective only when synthesis of the antigen is very high during the initial phase of invasion, while persistence of the S. typhimurium strain in deep tissues has only marginal influence.
| |
ACKNOWLEDGMENTS |
|---|
We are very grateful to Roy Curtiss III for providing plasmids and attenuated strains and for helpful advice. We thank Mariagrazia Pizza, Maria Teresa De Magistris, and Giuseppe Del Giudice for many valuable discussions and critical reading of the manuscript.
M.B. was supported by a CNPq/Rhae scholarship (260023/93.0) and by an UNIDO/ICGEB fellowship.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: IRIS, Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy. Phone: (577) 243485. Fax: (577) 243564. E-mail: galeotti{at}iris02.biocine.it.
Present address: Departamento de Genética e
Evolução, Instituto de Biologia, Universidade Estadual de
Campinas, Campinas, Brazil.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bost, K. L., and J. D. Clements. 1995. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 63:1076-1083[Abstract]. |
| 2. | Brocchi, M., M. G. Covone, E. Palla, and C. L. Galeotti. Unpublished data. |
| 3. | Cárdenas, L., and J. D. Clements. 1993. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine 11:126-135[Medline]. |
| 4. | Cárdenas, L., U. Dasgupta, and J. D. Clements. 1994. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 12:833-840[Medline]. |
| 5. | Chatfield, S. N., N. Fairweather, I. Charles, D. Pickard, M. Levine, D. Hone, M. Posada, R. A. Strugnell, and G. Dougan. 1992. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine 10:53-60[Medline]. |
| 6. |
Curtiss, R., III, and S. M. Kelly.
1987.
Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic.
Infect. Immun.
55:3035-3043 |
| 7. | Curtiss, R., III, S. M. Kelly, P. A. Gulig, and K. Nakayama. 1989. Selective delivery of antigens by recombinant bacteria. Curr. Top. Microbiol. Immunol. 146:35-49[Medline]. |
| 8. | Curtiss, R., III. 1990. Attenuated Salmonella strains as live vectors for the expression of foreign antigens, p. 161-188. In G. C. Woodrow, and M. M. Levine (ed.), New generation vaccines. Marcel Dekker, Inc., New York, N.Y. |
| 9. | Dallas, W. S., and S. Falkow. 1980. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature 288:499-501[Medline]. |
| 10. | Di Tommaso, A., G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G. Douce, and M. T. De Magistris. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:974-979[Abstract]. |
| 11. | Dougan, G. 1994. The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine development. Microbiology 140:215-224[Medline]. |
| 12. | Dougan, G., S. N. Chatfield, D. Pickard, D. O'Callaghan, and D. Maskell. 1988. Construction and characterization of Salmonella vaccine strains harbouring mutations in two different aro genes. J. Infect. Dis. 158:1329-1335[Medline]. |
| 13. | Galan, J. E., K. Nakayama, and R. Curtiss, III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella typhimurium. Gene 94:29-35[Medline]. |
| 14. |
Gentry-Weeks, C. R.,
A.-L. Hultsch,
S. M. Kelly,
J. M. Keith, and R. Curtiss, III.
1992.
Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium.
J. Bacteriol.
174:7729-7742 |
| 15. | Gyles, C. L., and D. A. Barnum. 1969. A heat-labile enterotoxin from strains of E. coli enteropathogenic for pigs. J. Infect. Dis. 120:419-426[Medline]. |
| 16. |
Hofstra, H., and B. J. Witholt.
1984.
Kinetics of synthesis, processing and membrane transport of heat-labile enterotoxin, a periplasmic protein in E. coli.
J. Biol. Chem.
259:15182-15187 |
| 17. | Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239[Medline]. |
| 18. | Hone, D., R. Morona, S. Attridge, and J. Hackett. 1987. Construction of a defined galE mutant of Salmonella for vaccine use. J. Infect. Dis. 156:167-174[Medline]. |
| 19. | Hone, D., A. M. Harris, S. Chatfield, G. Dougan, and M. M. Levine. 1991. Construction of genetically-defined double aro mutants of Salmonella typhi. Vaccine 9:810-816[Medline]. |
| 20. | Karem, K. L., S. Chatfield, N. Kuklin, and B. T. Rouse. 1995. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect. Immun. 63:4557-4563[Abstract]. |
| 21. | Magagnoli, C., R. Manetti, M. R. Fontana, V. Giannelli, M. M. Giuliani, R. Rappuoli, and M. Pizza. 1996. Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat-labile enterotoxin. Infect. Immun. 64:5434-5438[Abstract]. |
| 22. | Maskell, D. J., K. J. Sweeney, D. O'Callaghan, C. E. Hormaeche, F. Y. Liew, and G. Dougan. 1987. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune system. Microb. Pathog. 2:211-221[Medline]. |
| 23. | Miller, S. I., W. P. Loomis, C. Alpuche-Aranda, I. Behlau, and E. Hohmann. 1993. The PhoP virulence regulon and live oral Salmonella vaccines. Vaccine 11:122-125[Medline]. |
| 24. | Nakayama, K., S. M. Kelly, and R. Curtiss, III. 1988. Construction of an ASD+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6:693-697. |
| 25. | Oyston, P. C. F., E. D. Williamson, S. E. C. Leary, S. M. Eley, K. F. Griffin, and R. W. Titball. 1995. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect. Immun. 63:563-568[Abstract]. |
| 26. |
Pickard, D.,
J. Li,
M. Roberts,
D. Maskell,
D. Hone,
M. M. Levine,
G. Dougan, and S. Chatfield.
1994.
Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression.
Infect. Immun.
62:3984-3993 |
| 27. | Pizza, M., M. Domenighini, W. Hol, V. Giannelli, M. R. Fontana, M. M. Giuliani, C. Magagnoli, S. Peppoloni, R. Manetti, and R. Rappuoli. 1994. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol. Microbiol. 14:51-60[Medline]. |
| 28. |
Pizza, M.,
M. R. Fontana,
M. M. Giuliani,
M. Domenighini,
C. Magagnoli,
V. Giannelli,
D. Nucci,
W. Hol,
R. Manetti, and R. Rappuoli.
1994.
A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.
J. Exp. Med.
180:2147-2153 |
| 29. | Redman, T. K., C. C. Harmon, R. L. Lallone, and S. M. Michalek. 1995. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats. Infect. Immun. 63:2004-2011[Abstract]. |
| 30. | Rossolini, G. M., P. Muscas, A. Chiesurin, and G. Satta. 1993. Molecular cloning and expression in Escherichia coli of the Salmonella typhi gene cluster coding for type 1 fimbriae, p. 408-412. In F. Cabello, et al. (ed.), The biology of Salmonella. Plenum Publishing Co., New York, N.Y. |
| 31. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. . Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 32. |
Sanderson, K. E.,
A. Hessel, and K. E. Rudd.
1995.
Genetic map of Salmonella typhimurium, edition VIII.
Microbiol. Rev.
59:241-303 |
| 33. |
Schödel, F.,
S. M. Kelly,
D. L. Peterson,
D. R. Milich, and R. Curtiss, III.
1994.
Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.
Infect. Immun.
62:1669-1676 |
| 34. | Smith, H. W., and S. Halls. 1967. Escherichia coli enterotoxin. J. Pathol. Bacteriol. 93:531-543[Medline]. |
| 35. |
Spicer, E. K.,
W. M. Kavanaugh,
W. S. Dallas,
S. Falkow,
W. H. Konigsberg, and D. Shafer.
1981.
Sequence homologies between A subunits of E. coli and V. cholera enterotoxin.
Proc. Natl. Acad. Sci. USA
78:50-54 |
| 36. | Staats, H. F., R. J. Jackson, M. Marinaro, I. Takahashi, H. Kiyono, and J. R. McGhee. 1994. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immunol. 6:572-583[Medline]. |
| 37. |
Tacket, C. O.,
D. M. Hone,
R. Curtiss III,
S. M. Kelly,
G. Losonsky,
L. Guers,
A. M. Harris,
R. Edelman, and M. M. Levine.
1992.
Comparison of the safety and immunogenicity of aroC aroD and cya crp Salmonella typhi strains in adult volunteers.
Infect. Immun.
60:536-541 |
| 38. | Tsai, C. M., and C. E. Frash. 1983. A sensitive stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119. |
| 39. | Walker, R. I. 1994. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387-400[Medline]. |
| 40. | Zhang, T., and S. L. Stanley. 1996. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect. Immun. 64:1526-1531[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|